Objective The objective of this works was to assess the global prevalence of multidrug-
resistance among A. baumannii causing hospital-acquired (HAP) and ventilator-associated …

Acinetobacter pneumonia is a significant healthcare-associated infection that poses a
considerable challenge to clinicians due to its multidrug-resistant nature. Recent world …

Background: Acinetobacter baumannii is a common cause of multi-drug (MDR)-resistant
infections worldwide. The epidemiological and molecular characteristics of MDR-A …

Simple Summary The incidence and develo** status of multidrug-resistant bacteria and
fungi, as well as their related mortality, is reviewed by a systematic published literature …

Background To identify the epidemiology and mortality predictors of severe childhood
community-acquired pneumonia (CAP) and evaluate the influence of medications on clinical …

Abstract Purpose of Review Nosocomial extracardiac infections after cardiac surgery are a
major public health issue affecting 3–8.2% of patients within 30–60 days following the …

Multidrug-resistant A. baumannii (MDRAB) VAP has high morbidity and mortality, and the
rates are constantly increasing globally. Mono-and polybacterial MDRAB VAP might differ …

Aim: Efficacy of colistin and ampicillin–sulbactam have not been compared in treatment of
ventilator-associated pneumonia due to A. baumannii. Efficacy of colistin and ampicillin …

Antimicrobial resistance (AMR) is a worldwide health concern that continues to escalate. A
PubMed literature search identified articles from January 2015–August 2020 reviewing …

Comprehensive data on drug‐resistant patterns of Acinetobacter baumannii isolates in
develo** countries is limited. We conducted a multihospital study to assess the rate and …